Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma

L. V. Friedrich, R. L. White, M. B. Kays, D. S. Burgess

    Research output: Contribution to journalArticlepeer-review

    8 Scopus citations

    Abstract

    The hospital, pharmacy, and antibiotic costs for patients with penetrating abdominal trauma were compared with reimbursement received; these costs were also analyzed to assess the potential impact of a total prospective pricing system (PPS). During a four-year period, 46 patients admitted solely for penetrating abdominal trauma were retrospectively evaluated: their discharge summaries indicated that, for 9 patients, reimbursement was based on diagnosis-related groups (DRGs) under the PPS; 9 patients had private insurance; and 28 were classified as 'self-paying/no insurance.' All costs, corrected for inflation, were reported in 1989 dollars. Antibiotics represented 22.5%, 1.7%, and 0.5% of pharmacy, hospital, and DRG reimbursement, respectively; pharmacy costs were 8.5% of hospital costs and 2.3% of DRG reimbursement. For all 46 patients, a net loss of $295 per patient was incurred. Four patients accounted for 43% of the hospital costs. If the hospital had been reimbursed for all of these patients by prospective pricing and DRGs, it would have had a median profit of $9730 in 42 of 46 patients. Costs exceeded DRG reimbursement in the remaining four patients by a median of $8210. Antibiotic costs and pharmacy costs represent a small portion of hospital costs and DRG reimbursement for patients with penetrating abdominal trauma; thus, cost containment efforts in these patients should be directed at other ancillary services and length of stay.

    Original languageEnglish (US)
    Pages (from-to)590-594
    Number of pages5
    JournalAmerican Journal of Hospital Pharmacy
    Volume49
    Issue number3
    StatePublished - Jan 1 1992

    Keywords

    • Antibiotics
    • Costs
    • Diagnosis-related groups
    • Economics
    • Health care
    • Hospitals
    • Pharmacy, institutional, hospital
    • Reimbursement
    • Wounds and injuries

    ASJC Scopus subject areas

    • Leadership and Management
    • Pharmaceutical Science

    Fingerprint Dive into the research topics of 'Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma'. Together they form a unique fingerprint.

    Cite this